Neurology Devices Market Research Report - Global Forecast till 2027

Neurology Devices Market Trends, Growth and Size Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Neurosurgery Devices), End User (Hospitals & Clinics, Specialty Center) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

ID: MRFR/HC/8290-HCR | February 2021 | Region: Global | 90 Pages         

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Impact of Covid-19 on the Global Neurology Devices Market

5.3.1. Impact on Supply Chain

5.3.2. Impact on Pricing

5.3.3. Impact in Major Regions (Americas, Europe, Asia-Pacific, and Middle East & Africa)

6. GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT

6.1. Overview

6.2. Neurostimulation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.1. Spinal cord stimulation devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.2. Deep brain stimulation devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.3. Sacral nerve stimulation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.4. Vagus nerve stimulation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.2.5. Gastric electric stimulation

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Interventional neurology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1. Aneurysm coiling & embolization

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1.1. Embolic coils

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1.2. Flow diversion devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.1.3. Liquid embolic agents

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2. Cerebral balloon angioplasty & stenting

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2.1. Carotid artery stents

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2.2. Filter devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.2.3. Balloon occlusion devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3. Neurothrombectomy

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3.1. Clot retriever

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3.2. Suction aspiration devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3.3.3. Snares

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. CSF management

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.1. CSF shunts

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4.2. CSF drainage

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Neurosurgery devices

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.1. Ultrasonic aspirators

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.2. Stereotactic systems

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.3. Neuroendoscopes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5.4. Aneurysm clips

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL NEUROLOGY DEVICES MARKET, BY END USER

7.1. Overview

7.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Specialty Center

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL NEUROLOGY DEVICES MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Neurology Devices Market

9.5. Competitive Benchmarking

9.6. Leading Players in terms of Number of Developments in the Global Neurology Devices Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income, 2019

9.8.2. Major Players R&D Expenditure, 2019

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. B. Braun Melsungen AG

10.1.1. Company Overview

10.1.2. Product Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Boston Scientific Corporation.

10.2.1. Company Overview

10.2.2. Product Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Covidien PLC

10.3.1. Company Overview

10.3.2. Product Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Integra LifeSciences Holdings Corporation

10.4.1. Company Overview

10.4.2. Product Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Johnson and Johnson

10.5.1. Company Overview

10.5.2. Product Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. St. Jude Medical, Inc.

10.6.1. Company Overview

10.6.2. Product Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Stryker Corporation

10.7.1. Company Overview

10.7.2. Product Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. W.L. Gore & Associates, Inc.

10.8.1. Company Overview

10.8.2. Product Overview

10.8.3. Financial Overview

10.9. Key Developments

10.9.1. SWOT Analysis

10.9.2. Key Strategies

10.10. Esaote

10.10.1. Company Overview

10.10.2. Product Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Others

11. APPENDIX

11.1. References

11.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

β€’ In section 10, major 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, and Product Portfolio, Business Strategies, and Recent Development parameters.

β€’ Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources. 

LIST OF TABLES

TABLE 1 GLOBAL NEUROLOGY DEVICES MARKET SYNOPSIS, 2020–2027

TABLE 2 GLOBAL NEUROLOGY DEVICES MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

TABLE 3 GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 4 GLOBAL NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 5 GLOBAL NEUROLOGY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

TABLE 6 NORTH AMERICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 8 US: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 9 US: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 10 CANADA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 11 CANADA: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 12 LATIN AMERICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 13 LATIN AMERICA: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 14 EUROPE: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 15 EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: NEUROLOGY DEVICES MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)

 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEUROLOGY DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEUROLOGY DEVICES MARKET

FIGURE 4 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 5 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY END USER, 2019 (%)

FIGURE 6 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 7 AMERICAS: NEUROLOGY DEVICES MARKET SHARE BY REGION, 2019 (%)

FIGURE 7 NORTH AMERICA: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 8 EUROPE: NEUROLOGY DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 9 WESTERN EUROPE: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 10 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 GLOBAL NEUROLOGY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 13 BRAUN MELSUNGEN AG.: KEY FINANCIALS

FIGURE 14 BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 15 BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 16 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS

FIGURE 17 BOSTON SCIENTIFIC CORPORATION SEGMENTAL REVENUE

FIGURE 18 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE

FIGURE 19 INTEGRA LIFESCIENCES HOLDINGS CORPORATION

FIGURE 20 JOHNSON AND JOHNSON

FIGURE 21 MEDTRONIC INC.

FIGURE 22 ST. JUDE MEDICAL, INC

FIGURE 23 STRYKER CORPORATION

FIGURE 24 W.L. GORE & ASSOCIATES, INC.

FIGURE 25 MAGSTIM CO LTD.

Neurology Devices Market

Neurology Devices Market Is Projected To Reach $21,029.7 million, Enlisting a CAGR Of 10.2% By 2027

Segmentation

By Product Neurostimulation Interventional Neurology Csf Management Neurosurgery Devices
By End User Hospitals & Clinics Specialty Center

Key Players

  • Johnson and Johnson
  • L. Gore & Associates
  • Braun Mesungen AG
  • Jude Medical Inc.
  • Integra LifeSciences Holdings
  • Esaote
  • Boston Scientific
  • Stryker Corporation
  • Medtronic PLC (Ireland)
  • Rapid Medical
  • Acandis GmbH
  • MicroPort Scientific Corporation

Drivers

  • Growing Demand for Minimally Invasive Devices
  • Growing Geriatric Population.
Speak to Analyst Request a Free Sample

Market Overview


The Neurology Devices Market is projected to grow at a significant CAGR of 10.2%. The market value is also expected to expand up to USD 21,029.7 million in the studied forecast period 2020-2027. Neurology devices are used for treating the disease and various neurological disorders. They are pathophysiological conditions that occur in the nervous system, brain, and spinal cord.


Across 20 million people in America experienced several neuropathy disorders and around 16% of families comprise of an individual suffering from brain impairment. However, the growing awareness among people and technological advancement will lead the Americas region to dominate the market. Also, the Asia-Pacific region is evaluated to witness the fastest CAGR in the upcoming years.


COVID-19 Analysis


The COVID-19 disease has immensely impacted the Neurology Devices Market. As the outbreak began in 2019-2020, the industry of medical devices, as well as interventional neurology devices, was heavily impacted. Patients are also avoiding admitting the healthcare institutions to prevent contamination of disease.  Also, the manufacturing of medical devices was heavily impacted due to lockdown. However, various key players in the market are expected to improve the market in the upcoming years.


Market Dynamics


Market Drivers


There are several drivers such as increasing cases of neurological disorders, and expenditure of healthcare for the treatment of neurological disorders will fuel the market growth.


Restraints


The strict regulations by the government bodies and compliance standards of the neurology devices are expected to restraint the Neurology Devices Market Growth.


Opportunities


The rising demand for minimally invasive devices and the population of the older generation will offer new opportunities to the Neurology Devices Market.


Challenges


The high costs related to various neurological procedures can be challenging for the Neurology Devices Market in the upcoming years.


Cumulative Analysis


The Neurology Devices Market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 10.2%. In the upcoming years, the market value will further expand up o USD 21,029.7 in the studied forecast period 2020-2027. Various developments and support from the government bodies such as FDA compliance standards by the regulatory agencies will lead to lucrative growth in the upcoming years.


Value Chain Analysis


The improvement in the Neurology Devices Market Trends due to the increasing demand for technological development is a crucial factor. Along with that, the development by key players and the prevalence of various neurological disorders will further improve the value chain of the market.


Market Segmentations


The Neurology Devices Market Size is segmented into Product, Disease Pathology, and End-User. On the basis of Product, the market is segmented into Neurosurgery Devices, Interventional Neurology, Neurostimulation, and CSF Management. The segment of Neurostimulation is again divided into Deep Brain Stimulation Devices, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation, and Spinal Cord Stimulation Devices.


Furthermore, the Interventional Neurostimulation is again segmented into Embolization and Aneurysm Coiling (Liquid Embolic Agents, Flow Diversion Devices), Filter Devices, Neuro Thrombectomy, Stenting and Cerebral Balloon Angioplasty (Balloon Occlusion Devices, Filter Devices, and Carotid Artery Stents).


Along with that, CSG Management is again segmented into CSF Drainage and CSF Shunts. This procedure is used for the diagnosis of prognostication and severity such as infections, hemorrhage, etc.


However, the neurosurgery devices are again segmented into Stereotactic Systems, Aneurysm Clips, Ultrasonic Aspirators, and Neuroendoscopes.


On the basis of End-User, the market is again divided into Specialty Center and Clinics and Hospitals. The Clinics and Hospitals segment is expected to grow at a significant rate due to the increasing number of public and private hospitals. On the other hand, Specialty centers are expected to witness the fastest growth in the upcoming years.


On the basis of Disease Pathology, the Neurology Devices Market is divided into Cerebral Aneurysms, Fistulas and Arteriovenous Malformations, Ischemic Strokes, Carotid Artery Stenosis, and Others.


Regional Analysis


Geographically, the Neurology Devices Market is segmented into Europe, the Americas, Africa, and the Middle East, and Asia-Pacific. The Americas region is anticipated to hold the largest share in the studied forecast period. Hence, it is because of the rising cases of various neurological disorders. Also, supportive reimbursement schemes and the presence of various key players are enhancing the market growth in this region.


Furthermore, Europe in 2019 held the second-largest Neurology Devices Market Share. In the upcoming years, this region will also hold a considerable share with growing development in technology and support from the government.


Thirdly, the Asia-Pacific region is considered to grow at the fastest rate in the studied forecast period. According to the Neurology Devices Market Analysis by MRFR, around 30M people living in India have several neurological disorders. Apart from that, the increasing population of older people is also fuelling the CAGR in this region.


Africa and the Middle East region are anticipated to grow at a slower rate in the studied forecast period. It is mainly due to the slow growth rate in the healthcare infrastructure and awareness.


Competitive Landscape


The Neurology Devices Market is fragmented with the immense presence of various key players. These key players play a significant role in improving market growth. They do strategic developments such as market analysis, acquisitions, partnerships, new ventures, etc. Some of the key players in the Neurology Devices Market are as follows.



  • Johnson and Johnson

  • L. Gore & Associates

  • Braun Mesungen AG

  • Jude Medical Inc.

  • Integra LifeSciences Holdings

  • Esaote

  • Boston Scientific

  • Stryker Corporation

  • Medtronic PLC (Ireland)

  • Rapid Medical

  • Acandis GmbH

  • MicroPort Scientific Corporation

  • Perflow Medical

  • Lepu Medical


Recent Developments



  • Johnson and Johnson in 2021 announced the launch of a new product called Cerenovus Stroke Solutions. It comprises three devices to help in procedures of clot removal.

  • Pehnox in 2021 announced the establishment of the new entity to improve its business withhold in Europe.


Report Overview


The overview of the Neurology Devices Market Outlook is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation


The report score is to provide valuable information about the Neurology Devices Market Forecast in the studied forecast period 2021-2028. The report highlights the information about market players, drivers, challenges, opportunities, etc. Therefore, the information provided in this report is collected from several primary and secondary sources.



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2017-2020


Segmentation



  • By Product

  • Neurosurgery Devices

  • Interventional Neurology

  • Filter Devices

  • Neuro Thrombectomy

  • Stenting and Cerebral Balloon Angioplasty

  • Embolization

  • Aneurysm Coiling

  • Neurostimulation

  • Deep Brain Stimulation Devices

  • Vagus Nerve Stimulation

  • Sacral Nerve Stimulation

  • Gastric Electric Stimulation

  • Spinal Cord Stimulation Devices

  • CSF Management

  • CSF Drainage

  • CSF Shunts


 



  • By Disease Pathology

  • Cerebral Aneurysms

  • Fistulas and Arteriovenous Malformations

  • Ischemic Strokes

  • Carotid Artery Stenosis

  • Others


 



  • By End-User

  • Specialty Center

  • Clinics and Hospitals


 



  • By Region

  • Americas

  • Asia-Pacific

  • Europe

  • Africa and the Middle East



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 21,029.7 Million
  CAGR   10.2% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others
  Key Market Opportunities

  • Rising Prevalence of the Neurological Disorder.
  • Increasing Technological Advanced Devices.
  •   Key Market Drivers

  • Growing Demand for Minimally Invasive Devices.
  • Growing Geriatric Population.


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Global Neurology Devices Market is expected to record a substantial market valuation of USD 17.4 billion by 2027.

    Global Neurology Devices Market is projected to register a moderate 10.2% CAGR in the forecast period.

    The Neurostimulation segment is expected to observe substantial demand over the review period.

    The hospital and clinics segment is slated to expand as the fastest-growing segment.

    A few eminent market players operating in the global neurology devices market are Inc., Stryker Corporation, Medtronic Inc., and Esaote, among others.